Population subset | Placebo | Venlafaxine ER | ||
---|---|---|---|---|

37.5 mg | 75 mg | 150 mg | ||

Note: all P values were not significant. The P value for
gender was based on Fisher's exact test; the P values for age,
duration of current illness and baseline HRSA were based on ANOVA. | ||||

HRSA, Hamilton Rating Scale for Anxiety. | ||||

Intent-to-treat (n=529) | 130 | 138 | 130 | 131 |

Safety (n=541) | 130 | 140 | 134 | 137 |

Female n (%) | 76 (58) | 80 (57) | 83 (62) | 89 (65) |

Male n (%) | 54 (42) | 60 (43) | 51 (38) | 48 (35) |

Mean age (years) | 46.1 | 45.4 | 44.1 | 45 |

Range | 18-86 | 19-79 | 18-75 | 20-82 |

Mean duration of current illness (weeks) | 491.6 | 567 | 470.9 | 429.9 |

Mean baseline HRSA | 26.7 | 26.6 | 26.3 | 26.3 |

Range | 20-52 | 20-44 | 20-43 | 17-38 |